Pediatric Arrhythmia Management in Congenital Heart Disease (CHD): A 20-Year Epidemiologic Study and Therapeutic Insights at Imam-Reza Hospital (2001-2020)

Document Type : Original Article

Authors

1 Pediatric and Congenital Cardiology Division, Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Department of Cardiac Surgery, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

4 Department of Cardiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

5 Pediatric and Congenital Cardiology Division, Department of Pediatrics, Mashhad University of Medical Sciences, Mashhad, Iran

6 Department of Extra-Corporeal Circulation (ECC), Razavi Hospital, Imam Reza International University, Mashhad, Iran

Abstract

Background: Arrhythmia in children with congenital heart disease (CHD) can be due to abnormal anatomy, genetic mutations, hemodynamic abnormalities, primary myocardial disease, hypoxic tissue damage, or postoperative complications.

Objectives: This study aimed to investigate the epidemiological findings of children with various arrhythmias and their treatment outcomes.

Methods: The study was cross-sectional. The data were derived from 762 patients with arrhythmias, including tachyarrhythmias, bradyarrhythmias, and premature beats. The patient's demographic and clinical information, as well as their electrocardiogram (ECG), Holter monitor, echocardiography, and electrophysiology results, were collected and analyzed using SPSS software.

Results: The study found that 44.6% of the patients were female and 55.4% were male. The mean age of patients with tachyarrhythmias was 5.9 years, while those with bradyarrhythmias were 10 years old, and those with premature beats were 6.5 years old. The most common symptoms were palpitations, murmur, and slow pulse. The most common arrhythmias were supraventricular tachycardia (SVT) and premature atrial contractions (PACs).

Conclusion: The study revealed that cardiac abnormalities, including septal defects and valve abnormalities, were prevalent in patients with arrhythmias. Cardiomyopathy was associated with a higher risk of mortality. The study's findings emphasize the importance of paying attention to the presence of accompanying anomalies, palpitations, abnormal heart sounds, or bradycardia during the examination, as these are associated with an increased risk of mortality.

Keywords

Main Subjects


Acknowledgments: We thank the Pediatric and Congenital Cardiology Division, Department of Pediatrics, Mashhad University of Medical Sciences, Mashhad, Iran.

 

Availability of data and materials: The dataset presented in the study is available on request from the corresponding author during submission or after its publication.

 

Conflicts of Interest: The authors declare no conflicts of interest.

 

Consent for publication: Not applicable

 

Ethics approval and consent to participate: The Mashhad University of Medical Sciences ethics committee approved the study protocol with the number of IR.MUMS.REC.1399.493, which complies with the Declaration of Helsinki.

 

Financial disclosure: None.

 

Author contributions: H. M. M. S, M. T, and F. R: Contributed to the conception of the work, revising the draft, approving the final version of the manuscript, and agreeing on all aspects of the work; S. S, and S. Y: contributed to the critical revision, and approval of the final version of the manuscript; M. A. T, and M. H. M, Contributed to the conception and design of the study, critical revision, and approval of the manuscript's final version; N. S. M. Z, and M.Y., Contributed to the conception and design of the study, drafting of the manuscript and critical revision, and approval of final version.

 

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

1. Mullen M, Zhang A, Lui GK, Romfh AW, Rhee JW, Wu JC. Race and Genetics in Congenital Heart Disease: Application of iPSCs, Omics, and Machine Learning Technologies. Front Cardiovasc Med. 2021;8:635280.
https://doi.org/10.3389/fcvm.2021.635280
PMid:33681306 PMCid:PMC7925393
 
2. Warren PW, Powell AW, Knilans T, Connor C, Baskar S. Double Ventricular Response with Aberrant Conduction Leading to Ventricular Dysfunction. Pediatr Cardiol. 2025;46(2):499-503.
https://doi.org/10.1007/s00246-024-03506-9
PMid:38709261 PMCid:PMC11787247  
 
3. Naghibi Sistani M, Alizadeh B, Birjandi H, Mottaghi Moghaddam Shahri H, Fatemi Z, Shaye Z, et al. The Indispensable Role of Cardiac Catheterization Before Surgical Intervention of Pediatrics Undergoing Tetralogy of Fallot Total Correction; A Single Center Experience.Inn J Pediatr 2024;34(5):e147153.
https://doi.org/10.5812/ijp-147153  
 
4. Hosseinzadeh Maleki M, Mohammadi A, Askarzadeh S, Safari Soltanabad A, Daneshmand S, Samadieh F, Yaghubi M. The Biometric Approach as a Novel Modified Two-Patch Technique for Complete Atrioventricular Septal Defect Repair. Razavi International Journal of Medicine, 2025; 13(2):23-29.  
 
5. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular research. 2002;54(2):230-46.
https://doi.org/10.1016/S0008-6363(02)00258-4
PMid:12062329  
 
6. Holst KA, Said SM, Nelson TJ, Cannon BC, Dearani JA. Current interventional and surgical management of congenital heart disease: specific focus on valvular disease and cardiac arrhythmias. Circulation research. 2017;120(6):1027-44.
https://doi.org/10.1161/CIRCRESAHA.117.309186
PMid:28302746  
 
7. Neidenbach R, Niwa K, Oto O, Oechslin E, Aboulhosn J, Celermajer D, et al. Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part I: development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmia. Cardiovascular diagnosis and therapy. 2018;8(6):705.
https://doi.org/10.21037/cdt.2018.10.15
https://doi.org/10.21037/cdt.2018.10.16  
 
8. Brugada J, Blom N, Sarquella-Brugada G, Blomstrom-Lundqvist C, Deanfield J, Janousek J, et al. Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement. Europace. 2013;15(9):1337-82.
https://doi.org/10.1093/europace/eut082
PMid:23851511  
 
9. Huttelmaier MT, Fischer TH. Kardiale Kanalopathien im Kontext hereditärer Arrhythmiesyndrome [Cardiac channelopathies in the context of hereditary arrhythmia syndromes]. Inn Med (Heidelb). 2024;65(8):787-797. German.
https://doi.org/10.1007/s00108-024-01751-x
PMid:38977442 PMCid:PMC11269359  
 
10. Wazni O, Martin DO, Marrouche NF, Shaaraoui M, Chung M, Almahameed S, et al. C-reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart. 2005;91(10):1303-5.
https://doi.org/10.1136/hrt.2004.038661
PMid:15890767 PMCid:PMC1769138  
 
11. Zhang M, Cao X, Zhang Y. Combination of electrophysiological mapping, radiofrequency catheter ablation, and atrial appendectomy in a 5-year-old girl with tachycardia-induced cardiomyopathy: a case report. J Cardiothorac Surg. 2024;19(1):169.
https://doi.org/10.1186/s13019-024-02693-z
PMid:38566062 PMCid:PMC10986129  
 
12. Pfeiffer D, Tebbenjohanns J, Klein N, Metze M, Neef M. Geschichte der Katheterablation [History of catheter ablation]. Herzschrittmacherther Elektrophysiol. 2019;30(4):325-329. German.
https://doi.org/10.1007/s00399-019-00661-y
PMid:31758250  
 
13. Ponnusamy SS, Muthu G, Kumar M, Bopanna D, Anand V, Balasubramanian S. Safety, Efficacy, and Intermediate-Term Outcomes of Radiofrequency Catheter Ablation for Pediatric Arrhythmias. Cureus. 2020;12(9):e10488.
https://doi.org/10.7759/cureus.10488
PMid:33083188 PMCid:PMC7567299  
 
14. Talwar S, Patel K, Juneja R, Choudhary SK, Airan B. Early postoperative arrhythmias after pediatric cardiac surgery. Asian Cardiovascular and Thoracic Annals. 2015;23(7):795-801.
https://doi.org/10.1177/0218492315585457
PMid:25972292  
 
15. Isik DU, Celik IH, Kavurt S, Aydemir O, Kibar AE, Bas AY, et al. A case series of neonatal arrhythmias. The Journal of Maternal-Fetal & Neonatal Medicine. 2016;29(8):1344-7.
https://doi.org/10.3109/14767058.2015.1048679
PMid:26037725  
 
16. Badrawi N, Hegazy RA, Tokovic E, Lotfy W, Mahmoud F, Aly H. Arrhythmia in the neonatal intensive care unit. Pediatric cardiology. 2009;30:325-30.
https://doi.org/10.1007/s00246-008-9355-4
PMid:19184182  
 
17. Rękawek J, Kansy A, Miszczak-Knecht M, Manowska M, Bieganowska K, Brzezinska-Paszke M, et al. Risk factors for cardiac arrhythmias in children with congenital heart disease after surgical intervention in the early postoperative period. The Journal of thoracic and cardiovascular surgery. 2007;133(4):900-4.
https://doi.org/10.1016/j.jtcvs.2006.12.011
PMid:17382623  
 
18. Houck CA, Chandler SF, Bogers A, Triedman JK, Walsh EP, de Groot NMS, et al. Arrhythmia Mechanisms and Outcomes of Ablation in Pediatric Patients With Congenital Heart Disease. Circulation, Arrhythmia, and Electrophysiology. 2019;12(11):e007663.
https://doi.org/10.1161/CIRCEP.119.007663
PMid:31722541  
 
19. Alotaibi RK, Saleem AS, Alsharef FF, Alnemer ZA, Saber YM, Abdelmohsen GA, et al. Risk factors of early postoperative cardiac arrhythmia after pediatric cardiac surgery: A single-center experience. Saudi Medical Journal. 2022;43(10):1111-9.
https://doi.org/10.15537/smj.2022.43.10.20220275
PMid:36261205 PMCid:PMC9994501  
 
20. Yildirim SV, Tokel K, Saygili B, Varan B. The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients. The Turkish Journal of Pediatrics. 2008;50(6):549-53.